Question 1

Who are the top researchers at Athenex (United States)?

Accepted Answer

Ranked on the quality score, Francisco Barrios, Michael P. Smolinski and David L. Cutler lead among researchers whose main affiliation is Athenex (United States).

Question 2

What are the most cited papers from Athenex (United States)?

Accepted Answer

The most cited paper from Athenex (United States) is "Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors" (Elisabeth Buchdunger, Catherine L. Cioffi, Norman M. Law et al., 2000), with 1,284 citations. Next come "Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia" (897) and "Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial" (420).

Question 3

Which research topics does Athenex (United States) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Treatment and Pharmacology, Dental Implant Techniques and Outcomes, Ancient Mediterranean Archaeology and History and Dental Education, Practice, Research.

Question 4

Which keywords describe research at Athenex (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Late Antiquity, Metastatic Breast Cancer, Cancer Therapy, Metastasis, Ancient Rome, Greek Literature, Chemotherapy and Breast Cancer.

Question 5

Which fields of science does Athenex (United States) work in?

Accepted Answer

In all years, 39% of research at Athenex (United States) is in Health Sciences, 25% in Social Sciences. Its largest fields are Medicine (37%), Biochemistry, Genetics and Molecular Biology (15%), Social Sciences (11%). It does 1.6× the world's share of Health Sciences.

Question 6

Is Athenex (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 60% lower than in 2018-2021.